BASEL, Switzerland, le 14 déc. /CNW Telbec/ - Neuro-Biotech Corp.
(PINKSHEET: MRES) (OTCQB: MRES) announced today having now reached debt
free status, and currently planning its distribution program for 2011.
After 2 years of hard work and administrative organisation to finance
and bring to market the distribution of its products, Neuro-Biotech
Corp. is proud to inform its shareholders that it has repaid all debts
to third parties totalling the sum of one million, one hundred, twenty
five thousand and nine hundred thirteen dollars ($ 1,125,913).
"The team has been working non-stop to attain this level, and we now
have all green lights to begin a strategically planned series of
Scientific Speakerships and Road Shows in Europe and United States."
For more information on Neuro-Biotech Products: neuro-biotechcorp.com.
Forward Looking Statements
This release contains statements that are made pursuant to the Safe
Harbor Provisions of the Private Securities Litigation Act of 1995.
Certain statements in this press release may contain words such as
"anticipates," "believes," "could," "expects," "intends," "may,"
"projects," "targets" and other similar language that is considered
forward-looking statements. These forward-looking statements are
subject to certain risks and uncertainties and persons reading this
release are cautioned that such statements are only predictions, and
that the Company's actual future results or performance may be
materially different. The Company disclaims any intention or obligation
to update or revise forward-looking information, whether as a result of
new information, future events, or otherwise, could cause the company's
actual results to differ materially from those indicated in any
SOURCE Neuro-Biotech Corp.
For further information:
Dr. Claude Poulin
41 61 500 05 16